SHARE-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2024

SHARE-BASED COMPENSATION

SCHEDULE OF OPTION ACTIVITY UNDER 2021 PLAN AND 2018 PLAN

				Weighted-
				Average
				Remaining	Aggregate
		Weighted-Average		Contractual Term	Intrinsic Value
	Options	Exercise Price		(in years)	(in thousands)
Outstanding at December 31, 2023	5,230,344	$	13.66	8.16	$	49,728
Granted	1,396,691		19.75
Exercised	(133,282)		5.30
Cancelled/Forfeited	(30,990)		22.07
Outstanding at March 31, 2024	6,462,763	$	15.11	8.32	$	93,463
Vested and exercisable at March 31, 2024	2,440,412		12.04	7.65		42,791

SCHEDULE OF UNVESTED RESTRICTED STOCK UNIT ACTIVITY

		Weighted-
		Average Grant
		Date Fair Value
	Units	Per Unit
Unvested restricted stock units as of December 31, 2023	21,968	$	22.26
Granted	—		—
Vested	(2,776)		23.10
Forfeited	—		—
Unvested restricted stock units as of March 31, 2024	19,192	$	22.14

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION GRANTS

Stock-based compensation expense recognized for all equity awards has been reported in the statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended March 31,
	2024		2023
Research and development	$	2,494	$	1,299
General and administrative		1,706		1,085
Total	$	4,200	$	2,384

Stock-based compensation expense by type of award included within the consolidated statements of operations and comprehensive income (loss) was as follows:

	Three Months Ended March 31,
	2024		2023
Stock options	$	4,067	$	2,289
Restricted stock awards and units		47		48
Employee stock purchase plan awards		86		47
Total	$	4,200	$	2,384